SAN DIEGO, April 5, 2016 /PRNewswire/ -- Suneva Medical, Inc., a privately-held aesthetics company, today announced the launch of Regenica® Rejuvenating Dual Serum, the latest addition to the Regenica® skin care line. Backed by science and clinical data, the new serum represents a revolutionary breakthrough in skin care and was specifically developed to improve the appearance of skin tone, texture and brightness, as well as reduce the appearance of fine lines, wrinkles and pores. The powerful, dual chamber serum is created using the most advanced growth factor technology that combines a 95 percent concentration of MRCx™—a unique, proprietary blend of growth factors, cytokines and proteins—and anti-aging ingredients including advanced copper peptides, amino acids, antioxidants and plant-based extracts.
"Serums are growing in popularity for their ability to boost anti-aging results, but when adding a high concentration of MRCx™ to the formulation, the growth factors people lose with age are supplemented for a more youthful, confident and healthy appearance," said Dr. Ava Shamban, one of the country's leading authorities on skin rejuvenation, and assistant clinical professor of dermatology at UCLA. "For years my patients have turned to Regenica® to help reverse signs of aging and now with the new dual serum, their skin care regimens can pack an even more powerful punch as this next generation formula represents the most advanced growth factor product available today."
In a clinical study that is ongoing, women were asked to use Regenica® Rejuvenating Dual Serum on their entire face, twice daily. More than 97 percent of patients were satisfied with the serum at 30 days and would also recommend the product to a friend. When asked about the product's texture and color, 100 percent of patients were satisfied; 97 percent were satisfied with the smell.1 Statistically significant improvements were also reported as early as 14 days, with continued improvement seen at 30 days.1 Key parameters studied with positive results included the reduction in the appearance of fine lines, skin firmness, skin radiance and skin hydration. 1
"This is an important product in Suneva's anti-aging initiative. The positive data outcomes from the Regenica® Serum clinical study are fortified by the strong improvements and satisfaction experienced by patients," said Nicholas L. Teti, Jr., Chairman and Chief Executive Officer at Suneva Medical. "Regenica® Rejuvenating Dual Serum represents our newest flagship offering in a continuum of skin care products made from a highly scientific process that puts modern technology to work. Whether using the serum as a standalone product or in conjunction with other Regenica® creams and gels, this innovative serum can deliver impressive results."
In an independent study, 82 percent of respondents indicated the desire to incorporate a serum into their skin care routine. Ninety-two percent were somewhat to very likely to use a skin care system with growth factor technology that is formulated to reduce the look of fine lines and wrinkles.2 Regenica® Rejuvenating Dual Serum can be used twice daily to improve the overall appearance of skin on the face, neck and décolletage. The light, non-greasy and cosmetically elegant texture is ideal to use after cleansing and underneath an SPF-containing product or other moisturizing cream. It can be applied as a standalone skin care product or paired with Regenica® Revitalizing Eye Crème and all other offerings within the Regenica® line.
The popular Regenica® product line includes Regenica® Renew SPF 15, Regenica® Replenishing Crème, Regenica® Revitalizing Eye Crème, Regenica® Repair Complex, Regenica® Recovery Gel and now the new Regenica® Rejuvenating Dual Serum. To learn more about Regenica® or find a provider, visit www.regenica.com. Follow Regenica® on Facebook: facebook.com/regenicaskincare, Twitter: @RegenicaSkin and Instagram: RegenicaSkincare.
Regenica® and MRCx™ are trademarks of Suneva Medical, Inc.
About Suneva Medical, Inc.
Suneva Medical is a privately-held aesthetics company focused on developing, manufacturing and commercializing novel, differentiated products for the general dermatology and aesthetic markets. The innovative aesthetics leader markets Bellafill®, the only dermal filler on the market that is approved by the U.S. Food and Drug Administration for the correction of nasolabial folds and moderate to severe, atrophic, distensible facial acne scars on the cheek in patients over the age of 21 years. The company markets Bellafill® in the U.S., Canada and Hong Kong; ArteFill® in South Korea; Regenica® skin care in the U.S., Canada and Hong Kong; and ReFissa® tretinoin cream in the U.S. ArteFill® was rebranded to Bellafill® in the U.S. to reflect the transformational outcomes this unique product can provide to patients seeking correction of their acne scars and nasolabial folds. For more information, visit www.sunevamedical.com.
1Suneva Medical, data on file
2Havas Formula Independent Study, 2016
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/suneva-medical-advances-the-science-behind-youthful-skin-with-the-introduction-of-regenica-rejuvenating-dual-serum-300246135.html
SOURCE Suneva Medical, Inc.